Anger Clinical Trials

A listing of Anger medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 428 clinical trials
A Multicenter, Randomized, Placebo-Controlled, Multiple-Ascending-Dose Investigation of the Oral Anti-Inflammatory Agent BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) (SCOUT)

This is a randomised, double-blind, placebo-controlled study to assess the safety and tolerability of multiple ascending doses of BT051 in subjects with moderately to severely active ulcerative colitis. Subjects will be randomised using a 3 active:1 placebo ratio to 3 ascending dose cohorts of 8 subjects and will be dosed …

cancer
sulfasalazine
endoscopy
corticosteroids
prednisone
  • 0 views
  • 22 Oct, 2022
  • 6 locations
AVANCE-Houston Building Futures Program Evaluation

AVANCE seeks to understand if participation in the AVANCE-Houston Building Futures (A-HBF) program is associated with improved outcomes among the target population of at-risk, homeless, and incarcerated youth. Additionally, the evaluation will examine how and why participant-level characteristics such as relationship status, life status, and demographics are associated with greater …

Accepts healthy volunteers
  • 34 views
  • 14 Apr, 2022
  • 1 location
AVANCE-Houston FRAMEWorks Program Evaluation

AVANCE-Houston seeks to understand whether a standard or compressed schedule format for delivering the Survival Skills for Healthy Families curriculum better meets the needs of low-income adults to improve skill retention and, ultimately, to promote better outcomes for healthy family relationships and economic stability.

Accepts healthy volunteers
  • 0 views
  • 11 Mar, 2022
  • 1 location
Efficacy and Safety Study Exploring Nangibotide Treatment in COVID-19 pAtients With ventiLatory Support (ESSENTIAL) A Randomized, Double-blind, Placebo-controlled Study With Adaptive Features (ESSENTIAL)

This is a randomized, double-blind, placebo-controlled, in which one dose of nangibotide will be tested versus placebo. All patients with a diagnosis of COVID-19, and a requirement for respiratory support will be considered for study participation. The applicable local requirements for informed consent will be followed. Where permissible, an emergency …

  • 0 views
  • 15 Oct, 2022
  • 5 locations
Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation. (PROLISA)

The investigators propose to evaluate premedication with Propofol compared to a control strategy including a placebo with a possible rescue treatment with ketamine to ensure pain control before LISA Procedure . Investigators hypothesize that sedation with Propofol is safe and non-inferior to placebo for the risk of Mechanical Ventilation in …

  • 2 views
  • 18 Feb, 2022
  • 16 locations
Randomised, Double-blind, Placebo-controlled and Parallel Group Trial to Investigate the Effects of Two Doses (Up-titration to a Fixed Dose Regimen) of Oral BI 685509 on Portal Hypertension After 24 Weeks Treatment in Patients With Clinically Significant Portal Hypertension (CSPH) in Compensated Cirrhosis

This study is open to adults with liver cirrhosis and high blood pressure in the portal vein (main vessel going to the liver). The purpose of this study is to find out whether a medicine called BI 685509 helps people with this condition. Participants are put into 3 groups randomly, …

  • 1 views
  • 25 Oct, 2022
  • 34 locations
A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) (2002)

This is an open-label, randomized, Phase 3, multicenter trial, which has been designed to compare the efficacy and safety of T-Guard to ruxolitinib in patients with Grade III or IV Steroid-Refractory acute Graft-Versus-Host Disease (SR-aGVHD). The primary hypothesis is that T-Guard treatment will improve the Day 28 complete response (CR) …

  • 3 views
  • 07 Oct, 2022
  • 36 locations
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT)

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) suggest spironolactone may be effective in HFPEF, but it is generic and will not be studied by industry. SPIRRIT is …

nt-probnp
natriuretic peptide
b-type natriuretic peptide
n-terminal pro-bnp
atrial fibrillation
  • 69 views
  • 04 Oct, 2022
  • 67 locations
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) (C-PRECISE-01)

Open-label, dose-confirmation and cohort expansion, multicentre, Phase Ib/II study to assess the anti-tumour activity and safety of MEN1611 in combination with cetuximab for the treatment of patients with PIK3CA mutated metastatic colorectal cancer.

cetuximab
fluorouracil
irinotecan
adenocarcinoma of colon
PIK3CA
  • 22 views
  • 24 Mar, 2022
  • 24 locations
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)

This is a Phase 3 study to evaluate the efficacy, safety, and tolerability of crinecerfont versus placebo administered for 28 weeks in approximately 81 pediatric patients with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The study consists of a 28-week double blind, placebo-controlled period, followed by 24 weeks …

21-ohd
classic congenital adrenal hyperplasia
deficiency
  • 3 views
  • 07 Oct, 2022
  • 39 locations